Demant (DEMANC) Stock Overview
Operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
DEMANC Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Demant A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 209.60 |
| 52 Week High | DKK 283.50 |
| 52 Week Low | DKK 209.60 |
| Beta | 0.92 |
| 1 Month Change | -11.41% |
| 3 Month Change | -17.12% |
| 1 Year Change | -21.82% |
| 3 Year Change | 3.20% |
| 5 Year Change | -3.19% |
| Change since IPO | 100.96% |
Recent News & Updates
Recent updates
Shareholder Returns
| DEMANC | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | -8.3% | -2.4% | -3.9% |
| 1Y | -21.8% | 15.1% | 16.3% |
Return vs Industry: DEMANC underperformed the UK Medical Equipment industry which returned 11.9% over the past year.
Return vs Market: DEMANC underperformed the UK Market which returned 16.4% over the past year.
Price Volatility
| DEMANC volatility | |
|---|---|
| DEMANC Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 4.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 10.6% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine DEMANC's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1904 | 22,057 | Søren Nielsen | www.demant.com |
Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids and personalized hearing care products, as well as offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019.
Demant A/S Fundamentals Summary
| DEMANC fundamental statistics | |
|---|---|
| Market cap | DKK 45.16b |
| Earnings (TTM) | DKK 2.67b |
| Revenue (TTM) | DKK 22.59b |
Is DEMANC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DEMANC income statement (TTM) | |
|---|---|
| Revenue | DKK 22.59b |
| Cost of Revenue | DKK 5.46b |
| Gross Profit | DKK 17.13b |
| Other Expenses | DKK 14.46b |
| Earnings | DKK 2.67b |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 12.52 |
| Gross Margin | 75.83% |
| Net Profit Margin | 11.81% |
| Debt/Equity Ratio | 142.5% |
How did DEMANC perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/19 05:53 |
| End of Day Share Price | 2025/11/18 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Demant A/S is covered by 40 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | ABG Sundal Collier |
| Edward Ridley-Day | Barclays |
| Hassan Al-Wakeel | Barclays |